Detection of Adrenocorticotropin-Secreting Pituitary Adenomas by Magnetic Resonance Imaging in Children and Adolescents with Cushing Disease

Section on Endocrinology and Genetics, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Building 10, Room 10N262, 10 Center Drive, MSC 1862, Bethesda, Maryland 20892-1862, USA.
Journal of Clinical Endocrinology &amp Metabolism (Impact Factor: 6.21). 10/2005; 90(9):5134-40. DOI: 10.1210/jc.2004-1778
Source: PubMed


We recently showed that pre- and postcontrast spoiled gradient-recalled acquisition in the steady-state (SPGR) was superior to conventional pre- and postcontrast T-1 weighted spin echo (SE) acquisition magnetic resonance imaging (MRI) for the diagnostic evaluation of pituitary tumors in adult patients.
The present investigation assessed the use of SPGR vs. SE-MRI in the diagnostic evaluation of ACTH-secreting tumors in children and adolescents with Cushing disease.
Data were analyzed retrospectively from a series of patients seen over 7 yr (1997-2004).
The setting for this study was a tertiary care referral center.
Thirty children with Cushing disease (13 females and 17 males with a mean age of 12 +/- 3 yr) were studied.
Imaging results were compared with surgical and pathological findings and the clinical outcome.
Twenty-eight patients had microadenomas, and two had macroadenomas; the latter were identified by both MRI techniques. Precontrast SE and SPGR-MRI identified four and six of the microadenomas, respectively. Postcontrast SPGR-MRI identified the location of the tumor in 18 of 28 patients, whereas postcontrast SE-MRI identified the location and accurately estimated the size of the tumor in only five patients (P < 0.001).
We conclude that conventional MRI, even with contrast enhancement, mostly failed to identify ACTH-secreting microadenomas in children and adolescents with Cushing disease. Postcontrast SPGR-MRI was superior to SE-MRI and should be used in addition to conventional SE-MRI in the pituitary evaluation of children and adolescents with suspected Cushing disease.

Download full-text


Available from: Margaret F Keil,

Click to see the full-text of:

Article: Detection of Adrenocorticotropin-Secreting Pituitary Adenomas by Magnetic Resonance Imaging in Children and Adolescents with Cushing Disease

5.57 MB

See full-text
  • Source
    • "Dynamic contrast MRI has been reported to provide a diagnostic advantage for selected cases of small microadenomas and is recommended if standard pituitary MR imaging is negative [19]. Spoiled-gradient recall acquisition with thin-slice imaging has also been reported to substantially improve imaging resolution and the diagnosis of small microadenomas [20]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cushing's Disease is caused by oversecretion of ACTH from a pituitary adenoma and results in subsequent elevations of systemic cortisol, ultimately contributing to reduced patient survival. The diagnosis of Cushing's Disease frequently involves a stepwise approach including clinical, laboratory, neuroimaging, and sometimes interventional radiology techniques, often mandating multidisciplinary collaboration from numerous specialty practitioners. Pituitary microadenomas that do not appear on designated pituitary MRI or dynamic contrast protocols may pose a particularly challenging subset of this disease. The treatment of Cushing's Disease typically involves transsphenoidal surgical resection of the pituitary adenoma as a first-line option, yet may require the addition of adjunctive measures such as stereotactic radiosurgery or medical management to achieve normalization of serum cortisol levels. Vigilant long-term serial endocrine monitoring of patients is imperative in order to detect any recurrence that may occur, even years following initial remission. In this paper, a stepwise approach to the diagnosis, and various management strategies and associated outcomes in patients with Cushing's Disease are discussed.
    International Journal of Endocrinology 01/2013; 2013(2):893781. DOI:10.1155/2013/893781 · 1.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In personal communications systems, users contend for the resources of frequency and time, with re-use determined by the spatial separation, power allocation, antenna beam patterns, data rate, and the required signal to interference ratio for reliable operation. We describe a highly adaptive transceiver which implements distributed control of power, channel assignments, and antenna weights, to maximize the network throughput. That is, each link is optimized independently, with coupling only via the mutual interference
    Signals, Systems, and Electronics, 1995. ISSSE '95, Proceedings., 1995 URSI International Symposium on; 11/1995
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: : The accurate differential diagnosis of Cushing's syndrome is essential for appropriate and effective treatment. The initial step in the differential diagnosis of Cushing's syndrome is to distinguish between adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome (pituitary or nonpituitary ACTH-secreting neoplasm) and ACTH-independent hypercortisolism (due to a functioning adrenal neoplasm, autonomous bilateral adrenal nodular hyperplasia, or factitious/iatrogenic Cushing's syndrome). The measurement of plasma ACTH (immunometric assay) and its response to corticotropin-releasing hormone (CRH) will reliably distinguish ACTH-dependent from ACTH-independent Cushing's syndrome. A common sense approach, considering the patient's age and sex, duration of symptoms, and plasma potassium, ACTH, and urine free cortisol levels, will provide an accurate diagnosis in most. The high-dose dexamethasone suppression test (DST) has no incremental value in the differential diagnosis of Cushing's syndrome and an accuracy of only 80%. Although DST provides great theater, it should be abandoned. Pituitary magnetic resonance imaging (MRI) scans are positive in 25 to 45% of patients with Cushing's disease and in 10 to 15% of patients with ectopic ACTH. If the clinical features suggest pituitary Cushing's, an unequivocally positive MRI scan has good predictive value. The peripheral CRH stimulation test demonstrates a blunted ACTH response to CRH (<35% of basal) in most patients with ectopic ACTH; however, the probability of Cushing's disease is high at all levels of response. Finally, inferior petrosal sinus sampling with CRH stimulation has emerged as the most reliable study in the differential diagrnosis of ACTH-dependent Cushing's syndrome. (C) Lippincott-Raven Publishers.
    The Endocrinologist 12/1996; 7(1). DOI:10.1097/00019616-199707011-00004 · 0.12 Impact Factor
Show more